This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Atopic Dermatitis
and you are
between 2 and 6
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to assess the clinical effectiveness of Montelukast in children (2~6 years old) with atopic dermatitis and identify the pathophysiologic background of Montelukast on the role of modulating the atopic dermatitis measured by urinary Leukotriene 4 (LTE4) and Eosinophil protein X(EDN).

Provided treatments

  • Drug: Montelukast first, then placebo
  • Drug: Placebo first, then Montelukast
Tris trial is registered with FDA with number: NCT00903357. The sponsor of the trial is Pyun BokYang and it is looking for 54 volunteers for the current phase.
Official trial title:
A Double Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Koreans